Cliff Asness’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.4M Buy
2,566,241
+2,310,746
+904% +$14.1M 0.01% 1040
2026
Q1
$1.95M Buy
+255,495
New +$1.95M ﹤0.01% 2359
2025
Q3
Sell
-12,212
Closed -$113K 3569
2025
Q2
$113K Sell
12,212
-1,039
-8% -$9.07K ﹤0.01% 3155
2025
Q1
$129K Sell
13,251
-2,058
-13% -$25.5K ﹤0.01% 2966
2024
Q4
$185K Sell
15,309
-12,477
-45% -$152K ﹤0.01% 2685
2024
Q3
$305K Buy
+27,786
New +$282K ﹤0.01% 2388
2024
Q1
Sell
-17,825
Closed -$150K 2488
2023
Q4
$150K Buy
+17,825
New +$207K ﹤0.01% 2248
2023
Q3
Sell
-11,290
Closed -$262K 2368
2023
Q2
$262K Buy
11,290
+126
+1% +$2.46K ﹤0.01% 1989
2023
Q1
$197K Buy
+11,164
New +$265K ﹤0.01% 2054
2021
Q3
Sell
-15,279
Closed -$587K 2314
2021
Q2
$587K Sell
15,279
-4,563
-23% -$156K ﹤0.01% 1834
2021
Q1
$605K Sell
19,842
-8,562
-30% -$321K ﹤0.01% 1764
2020
Q4
$1.08M Sell
28,404
-10,923
-28% -$455K ﹤0.01% 1461
2020
Q3
$905K Buy
39,327
+3,738
+11% +$85.2K ﹤0.01% 1459
2020
Q2
$884K Sell
35,589
-8,962
-20% -$159K ﹤0.01% 1510
2020
Q1
$444K Buy
+44,551
New +$664K ﹤0.01% 1623

Other funds holding REPL

Cliff Asness's REPL Position: Q2 2026 in Review

Cliff Asness increased its Replimune Group (REPL) stake by 904% in Q2 2026, buying an estimated $14.1M and bringing the position to 2,566,241 shares worth $28.4M. The position accounts for 0.01% of the portfolio, ranked #1040.

Cliff Asness first reported a position in REPL in Q1 2020 and has held it in 15 quarters since. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Cliff Asness held 2,566,241 shares of Replimune Group worth $28.4M as of Q2 2026.
  • Cliff Asness bought 2,310,746 Replimune Group shares in Q2 2026, an estimated $14.1M.
  • Replimune Group made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1040 holding.
  • Cliff Asness first reported a position in Replimune Group in Q1 2020 and has held it in 15 quarters since.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.